Results 111 to 120 of about 99,828 (263)

Blood flow dynamics in patient specific arterial network in head and neck [PDF]

open access: yes, 2011
This paper shows a steady simulation of blood flow in the major head and neck arteries as if they had rigid walls, using patient specific geometry and CFD software FLUENT R .
Campbell, D.F.   +3 more
core  

Resin Based Materials used to Observing the Variations of the Origin of the Superior Thyroid Artery with Importance in Cervical and Cranial Pathology

open access: yesMateriale plastice, 2019
The superior thyroid artery shows a great variability in what concerns its origin. Most often, it appears as an independent branch of the external carotid artery, as its first collateral branch, or directly from the common carotid or at its terminal ...
P. Bordei   +6 more
semanticscholar   +1 more source

Vascular Supply of Laryngeal Paragangliomas: Case Report and Systematic Review

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Laryngeal paragangliomas are rare, highly vascularized, neuroendocrine tumors. Although surgical resection of these vascular neoplasms is associated with a known risk of significant hemorrhage, the vascular supply of laryngeal paragangliomas has been poorly characterized. Data Sources MEDLINE Ovid, Embase, Scopus, and Google Scholar.
Jane Y. Tong   +3 more
wiley   +1 more source

Blokada gornjih dišnih putova u zbrinjavanju otežanog dišnog puta u budnom stanju [PDF]

open access: yes, 2016
Airway anesthesia is pivotal for successful awake intubation provided either topically or by blocks. Airway blocks are considered technically more difficult to perform and carry a higher risk of complications.
Tatjana Stopar Pintarič
core   +2 more sources

Interventional oncology in children: Where are we now?

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel   +1 more
wiley   +1 more source

Bilateral anatomical variation in branching pattern of external carotid artery in a male cadaver: A case report

open access: yesRussian Open Medical Journal, 2014
Developmental anomalies in the origin and branching pattern of the external carotid artery are not common. The level of the bifurcation of the common carotid artery and also the variations in the origin/branching pattern of the external carotid artery ...
Laxman Khanal   +3 more
doaj   +1 more source

Superior Thyroid Artery Arising From the Common Carotid Artery- Potential Source for Unpredicted Intraoperative Bleeding- A Cadaveric Case Report

open access: yesAcademia Anatomica International, 2019
Superior thyroid artery usually arises from the anterior surface of external carotid artery as its first branch. Superior thyroid artery forms an important collateral circulation in case of unilateral occlusion of common carotid artery.
B. Anitha, S. Shanthini
semanticscholar   +1 more source

Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Over 5000 patients are newly diagnosed with Alopecia areata (AA) in Australia each year. AA severity varies from a single small patch to complete loss of scalp hair, body hair including eyelashes and eyebrows. Approximately 40% of affected individuals experience only a single patch and achieve spontaneous, complete and durable remission within
Daniella Kushnir‐Grinbaum   +19 more
wiley   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy